Status and phase
Conditions
Treatments
About
Safety, tolerability and pharmacokinetics of single and multiple oral doses of BI 113608 in healthy Chinese, Japanese and Caucasian male volunteers.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
-Healthy male volunteers according to the following criteria: Based upon a complete medical history, including the physical examination, vital signs (Blood Pressure, Pulse Rate), 12-lead Electrocardiogram, clinical laboratory tests
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
98 participants in 8 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal